Mostrar el registro sencillo del ítem

dc.contributor.authorLópez-Muñiz Ballesteros, Belén
dc.contributor.authorLópez de Andrés, Ana
dc.contributor.authorJiménez-García, Rodrigo
dc.contributor.authorZamorano-León, Jose J.
dc.contributor.authorCarabantes-Alarcón, David
dc.contributor.authorCuadrado-Corrales, Natividad
dc.contributor.authorDel-Barrio, José L.
dc.contributor.authorPérez-Farinós, José Napoleón 
dc.contributor.authorDe-Miguel-Díez, Javier
dc.date.accessioned2023-06-30T06:48:38Z
dc.date.available2023-06-30T06:48:38Z
dc.date.created2023-06-29
dc.date.issued2023-05-24
dc.identifier.citationLópez-Muñiz Ballesteros B, Lopez-de-Andres A, Jimenez-Garcia R, Zamorano-Leon JJ, Carabantes-Alarcon D, Cuadrado-Corrales N, Del-Barrio JL, Perez-Farinos N, De Miguel-Díez J. Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020. Healthcare. 2023; 11(11):1534. https://doi.org/10.3390/healthcare11111534es_ES
dc.identifier.urihttps://hdl.handle.net/10630/27132
dc.description.abstractBackground: This paper aims to assess temporal trends (2016–2020) in incidence, patient’s characteristics, complications, length of hospital stay (LOHS) and in-hospital mortality (IHM) among patients with and without idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation (LTx). We also analyse the effect of the COVID-19 pandemic on LTx in these populations. (2) Methods: A retrospective, population-based observational study was conducted using the Spanish National Hospital Discharge Database. Multivariable adjustment was conducted with logistic regression to analyse the IHM. (3) Results: We identified 1777 admissions for LTx during the study period, of which 573 (32.2%) were performed in patients with IPF. The number of hospital admissions for LTx rose from 2016 to 2020, both in patients with and without IPF, but a marked reduction was observed from year 2019 to year 2020. Over time, the proportion of single LTx decreased and bilateral LTx increased significantly in both groups. The incidence of LTx complications increased significantly over time along with the increase in the incidence of IPF. No significant differences in the incidence of complications or in the IHM between patients with and without IPF were found. Suffering any complication of the LTx and pulmonary hypertension were conditions positively associated with IHM in patients with and without IPF. The IHM remained stable from 2016 to 2020 in both study populations and was not affected by the COVID pandemic. (4) Conclusions: Patients with IPF account for almost a third of all lung transplants. The number of LTx increased over time in patients with and without IPF, but a marked reduction was observed from 2019 to 2020. Although the proportion of LTx complications increased significantly over time in both groups, the IHM did not change. IPF was not associated with increased complications or IHM after LTx.es_ES
dc.description.sponsorshipPartial funding for open access charge: Universidad de Málagaes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectFibrosis pulmonares_ES
dc.subjectPulmón - Trasplantees_ES
dc.subject.otherCOVID-19 pandemices_ES
dc.subject.otherLung transplantes_ES
dc.subject.otherIdiopathic pulmonary fibrosises_ES
dc.subject.otherIncidencees_ES
dc.subject.otherComplicationses_ES
dc.subject.otherIn-hospital mortalityes_ES
dc.titleTrends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020.es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.centroFacultad de Cienciases_ES
dc.identifier.doi10.3390/healthcare11111534
dc.rights.ccAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional